Abstract
108P Real-world time on treatment (rwToT) analysis for first-line pembrolizumab combination therapy in advanced nonsquamous NSCLC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s1556-0864(21)01950-x
Journal: Journal of Thoracic Oncology | Publication Date: Mar 27, 2021 |
Citations: 1 |
108P Real-world time on treatment (rwToT) analysis for first-line pembrolizumab combination therapy in advanced nonsquamous NSCLC
Join us for a 30 min session where you can share your feedback and ask us any queries you have